Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$900K

Regulus Therapeutics Inc. (RGLS) Class Action Lawsuit (January 2017)

Closed

3:17cv182 • January 31, 2017

Class Period Start

February 17, 2016

Class Period End

June 11, 2017

PSLRA Deadline

April 3, 2017

Case Allegations

10b5

Statutes of Repose

Feb 17, 2019

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

September 14, 2020

Settlement Fund

$900,000

Settlement Status

Disbursed

Settlement Class

All persons or entities that PURCHASED OR OTHERWISE ACQUIRED REGULUS THERAPEUTICS INC. (“REGULUS”) COMMON STOCK BETWEEN FEBRUARY 17, 2016 AND JUNE 11, 2017, INCLUSIVE

Claim Administrator

Analytics Consulting, LLC
Regulus Securities Litigation Claims Administrator, Analytics Consulting LLC P.O. Box 2002 Chanhassen, MN 55317-2002
+1 844-913-1257
[email protected]

Hearing Date

October 21, 2020

Opt-out Deadline

September 16, 2020

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Jan 9, 2023

Disbursement Approved

The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.

Oct 30, 2020

Final Approval of Settlement

The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.

Jun 10, 2020

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

May 27, 2020

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

Oct 1, 2019

Second Amended Complaint

A new complaint has been filed on behalf of certain investors in Regulus Therapeutics Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

View all Updates

TOP